our cornerstone investor, page-6

Certainly encouraging, and it is relevant in my view, this is a drug from the same stable, and definitely give a bit more confidence on the outlook had the next results come positive.

But also notice how things took their time, this is a stage II drug, the successful result were announced in January, Pfizer only moved in now 11 months later, nothing moves fast enough in the biotech world.

Good find Cabe, I think the woody comment will stick for a while, but wait, maybe ALT1104 will come to fix that... or perhaps the lack of it.